Literature DB >> 28542676

Detailed Clinical Phenotype and Molecular Genetic Findings in CLN3-Associated Isolated Retinal Degeneration.

Cristy A Ku1, Sarah Hull2, Gavin Arno2, Ajoy Vincent3, Keren Carss4, Robert Kayton5, Douglas Weeks5, Glenn W Anderson6, Ryan Geraets7, Camille Parker7, David A Pearce8, Michel Michaelides2, Robert E MacLaren9, Anthony G Robson2, Graham E Holder2, Elise Heon3, F Lucy Raymond10, Anthony T Moore11, Andrew R Webster2, Mark E Pennesi1.   

Abstract

Importance: Mutations in genes traditionally associated with syndromic retinal disease are increasingly found to cause nonsyndromic inherited retinal degenerations. Mutations in CLN3 are classically associated with juvenile neuronal ceroid lipofuscinosis, a rare neurodegenerative disease with early retinal degeneration and progressive neurologic deterioration, but have recently also been identified in patients with nonsyndromic inherited retinal degenerations. To our knowledge, detailed clinical characterization of such cases has yet to be reported. Objective: To provide detailed clinical, electrophysiologic, structural, and molecular genetic findings in nonsyndromic inherited retinal degenerations associated with CLN3 mutations. Design, Setting, and Participants: A multi-institutional case series of 10 patients who presented with isolated nonsyndromic retinal disease and mutations in CLN3. Patient ages ranged from 16 to 70 years; duration of follow-up ranged from 3 to 29 years. Main Outcomes and Measures: Longitudinal clinical evaluation, including full ophthalmic examination, multimodal retinal imaging, perimetry, and electrophysiology. Molecular analyses were performed using whole-genome sequencing or whole-exome sequencing. Electron microscopy studies of peripheral lymphocytes and CLN3 transcript analysis with polymerase chain reaction amplification were performed in a subset of patients.
Results: There were 7 females and 3 males in this case series, with a mean (range) age at last review of 37.1 (16-70) years. Of the 10 patients, 4 had a progressive late-onset rod-cone dystrophy, with a mean (range) age at onset of 29.7 (20-40) years, and 6 had an earlier onset rod-cone dystrophy, with a mean (range) age at onset of 12.1 (7-17) years. Ophthalmoscopic examination features included macular edema, mild intraretinal pigment migration, and widespread atrophy in advanced disease. Optical coherence tomography imaging demonstrated significant photoreceptor loss except in patients with late-onset disease who had a focal preservation of the ellipsoid zone and outer nuclear layer in the fovea. Electroretinography revealed a rod-cone pattern of dysfunction in 6 patients and were completely undetectable in 2 patients. Six novel CLN3 variants were identified in molecular analyses. Conclusions and Relevance: This report describes detailed clinical, imaging, and genetic features of CLN3-associated nonsyndromic retinal degeneration. The age at onset and natural progression of retinal disease differs greatly between syndromic and nonsyndromic CLN3 disease, which may be associated with genotypic differences.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28542676      PMCID: PMC5710208          DOI: 10.1001/jamaophthalmol.2017.1401

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  70 in total

Review 1.  Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.

Authors:  Sara E Mole; Ruth E Williams; Hans H Goebel
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

2.  AP-1 and AP-3 facilitate lysosomal targeting of Batten disease protein CLN3 via its dileucine motif.

Authors:  Aija Kyttälä; Kristiina Yliannala; Peter Schu; Anu Jalanko; J Paul Luzio
Journal:  J Biol Chem       Date:  2004-12-13       Impact factor: 5.157

3.  Novel morphological macular findings in juvenile CLN3 disease.

Authors:  S Dulz; L Wagenfeld; M Nickel; G Richard; R Schwartz; U Bartsch; A Kohlschütter; A Schulz
Journal:  Br J Ophthalmol       Date:  2015-10-20       Impact factor: 4.638

4.  Vision loss as the presenting sign in juvenile neuronal ceroid lipofuscinosis.

Authors:  L I Bohra; J S Weizer; A G Lee; R A Lewis
Journal:  J Neuroophthalmol       Date:  2000-06       Impact factor: 3.042

Review 5.  ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition).

Authors:  Donald C Hood; Michael Bach; Mitchell Brigell; David Keating; Mineo Kondo; Jonathan S Lyons; Michael F Marmor; Daphne L McCulloch; Anja M Palmowski-Wolfe
Journal:  Doc Ophthalmol       Date:  2011-10-30       Impact factor: 2.379

6.  Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements.

Authors:  Feng Wang; Hui Wang; Han-Fang Tuan; Duy H Nguyen; Vincent Sun; Vafa Keser; Sara J Bowne; Lori S Sullivan; Hongrong Luo; Ling Zhao; Xia Wang; Jacques E Zaneveld; Jason S Salvo; Sorath Siddiqui; Louise Mao; Dianna K Wheaton; David G Birch; Kari E Branham; John R Heckenlively; Cindy Wen; Ken Flagg; Henry Ferreyra; Jacqueline Pei; Ayesha Khan; Huanan Ren; Keqing Wang; Irma Lopez; Raheel Qamar; Juan C Zenteno; Raul Ayala-Ramirez; Beatriz Buentello-Volante; Qing Fu; David A Simpson; Yumei Li; Ruifang Sui; Giuliana Silvestri; Stephen P Daiger; Robert K Koenekoop; Kang Zhang; Rui Chen
Journal:  Hum Genet       Date:  2013-10-24       Impact factor: 4.132

Review 7.  Pheno/genotypic correlations of neuronal ceroid lipofuscinoses.

Authors:  K E Wisniewski; N Zhong; M Philippart
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

8.  The juvenile Batten disease protein, CLN3, and its role in regulating anterograde and retrograde post-Golgi trafficking.

Authors:  Susan L Cotman; John F Staropoli
Journal:  Clin Lipidol       Date:  2012-02

9.  Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.

Authors:  Chun-Hung Chan; Hannah M Mitchison; David A Pearce
Journal:  Hum Mol Genet       Date:  2008-08-04       Impact factor: 6.150

10.  Alterations in ROS activity and lysosomal pH account for distinct patterns of macroautophagy in LINCL and JNCL fibroblasts.

Authors:  José Manuel Vidal-Donet; Jaime Cárcel-Trullols; Bonaventura Casanova; Carmen Aguado; Erwin Knecht
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more
  28 in total

1.  Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3).

Authors:  Fred K Chen; Xiao Zhang; Jonathan Eintracht; Dan Zhang; Sukanya Arunachalam; Jennifer A Thompson; Enid Chelva; Dominic Mallon; Shang-Chih Chen; Terri McLaren; Tina Lamey; John De Roach; Samuel McLenachan
Journal:  Doc Ophthalmol       Date:  2018-11-16       Impact factor: 2.379

2.  Gene Therapy Targeting the Inner Retina Rescues the Retinal Phenotype in a Mouse Model of CLN3 Batten Disease.

Authors:  Sophia-Martha Kleine Holthaus; Mikel Aristorena; Ryea Maswood; Olha Semenyuk; Justin Hoke; Aura Hare; Alexander J Smith; Sara E Mole; Robin R Ali
Journal:  Hum Gene Ther       Date:  2020-07       Impact factor: 5.695

3.  A diagnostic confidence scheme for CLN3 disease.

Authors:  Margaux C Masten; Camille Corre; Alex R Paciorkowski; Amy Vierhile; Heather R Adams; Jennifer Vermilion; Grace A Zimmerman; Erika F Augustine; Jonathan W Mink
Journal:  J Inherit Metab Dis       Date:  2021-09-07       Impact factor: 4.750

4.  Residual rod function in CNGB1 mutant dogs.

Authors:  Simon M Petersen-Jones; Nathaniel Pasmanter; Laurence M Occelli; Janice R Querubin; Paige A Winkler
Journal:  Doc Ophthalmol       Date:  2022-09-15       Impact factor: 1.854

5.  Biallelic variants in coenzyme Q10 biosynthesis pathway genes cause a retinitis pigmentosa phenotype.

Authors:  Neringa Jurkute; Francesca Cancellieri; Lisa Pohl; Catherina H Z Li; Robert A Heaton; Janine Reurink; James Bellingham; Mathieu Quinodoz; Georgia Yioti; Maria Stefaniotou; Marianna Weener; Theresia Zuleger; Tobias B Haack; Katarina Stingl; Carel B Hoyng; Omar A Mahroo; Iain Hargreaves; F Lucy Raymond; Michel Michaelides; Carlo Rivolta; Susanne Kohl; Susanne Roosing; Andrew R Webster; Gavin Arno
Journal:  NPJ Genom Med       Date:  2022-10-20       Impact factor: 6.083

Review 6.  Therapeutic landscape for Batten disease: current treatments and future prospects.

Authors:  Tyler B Johnson; Jacob T Cain; Katherine A White; Denia Ramirez-Montealegre; David A Pearce; Jill M Weimer
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

7.  Gene correction of the CLN3 c.175G>A variant in patient-derived induced pluripotent stem cells prevents pathological changes in retinal organoids.

Authors:  Xiao Zhang; Dan Zhang; Jennifer A Thompson; Shang-Chih Chen; Zhiqin Huang; Luke Jennings; Terri L McLaren; Tina M Lamey; John N De Roach; Fred K Chen; Samuel McLenachan
Journal:  Mol Genet Genomic Med       Date:  2021-01-26       Impact factor: 2.183

8.  Inherited Retinal Disease Panels-Caveat Emptor-Truly Know Your Inherited Retinal Disease Panel.

Authors:  Jose S Pulido; Rebecca Procopio; Hiram J Davila; Nicholas Bello; Cristy Ku; Mark E Pennesi; Paul Yang; Aaron Nagiel; Omar A Mahroo; Tomas S Aleman; Ezequiel M Salido; Margaret Reynolds
Journal:  Retina       Date:  2022-01-01       Impact factor: 4.256

9.  Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.

Authors:  Yu Zhong; Kabhilan Mohan; Jinpeng Liu; Ahmad Al-Attar; Penghui Lin; Robert M Flight; Qiushi Sun; Marc O Warmoes; Rahul R Deshpande; Huijuan Liu; Kyung Sik Jung; Mihail I Mitov; Nianwei Lin; D Allan Butterfield; Shuyan Lu; Jinze Liu; Hunter N B Moseley; Teresa W M Fan; Mark E Kleinman; Qing Jun Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-06-25       Impact factor: 6.633

10.  A genetic and clinical study of individuals with nonsyndromic retinopathy consequent upon sequence variants in HGSNAT, the gene associated with Sanfilippo C mucopolysaccharidosis.

Authors:  Elena R Schiff; Malena Daich Varela; Anthony G Robson; Karen Pierpoint; Rola Ba-Abbad; Savita Nutan; Wadih M Zein; Ehsan Ullah; Laryssa A Huryn; Sari Tuupanen; Omar A Mahroo; Michel Michaelides; Derek Burke; Katie Harvey; Gavin Arno; Robert B Hufnagel; Andrew R Webster
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-08-07       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.